Clinical Trial Update: A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers [Phase 1]

View source ↗

Summary

Phase I pharmacokinetic study to estimate how ketoconazole and omeprazole affect the exposure of dimebon in healthy volunteers, including both normal and poor C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Huntington Disease

Drugs mentioned

• Dimebon (latrepirdine)
• Ketoconazole (Ketoconazole)
• Omeprazole (Omeprazole)

Snippet

Sponsor: Pfizer | Conditions: Alzheimer's Disease, Huntington's Disease | Phase 1 | Status: COMPLETED